← All diseases Cancer

Lung cancer (non-small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the toughest evidence (186)Meta-analysis (67)Treatment guideline (1)Randomized trial (51)Systematic review (38)Phase 3 study (29)Clinical Research (661)Review article (246)Early Study (Phase 1 or 2) (77)Case report (126)Laboratory or animal research (69)Commentary or Editorial (87)Retracted publication (14) Only studies that are currently seeking participants (78)

Filter

Publications and studies (3237)

• Immunosenescence and immunotherapy in older NSCLC patients. (2024/01/01) ♡
• Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study. (2024/01/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Oral Decoctions Based on Qi-Yin Syndrome Differentiation After Adjuvant Chemotherapy in Resected Stage III A Non-Small Cell Lung Cancer: A Randomized Controlled Trial. (2024/01/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations. (2024/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Herbal Medicines for the Improvement of Immune Function in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. (2024/01/01) ♡
• The antitumour efficacy of hesperidin vs. cisplatin against non-small lung cancer cells A549 and H460 via targeting the miR-34a/PD-L1/NF-κb signalling pathway. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complete Response of Locally Advanced Lung Adenocarcinoma Following Basil Combined With Cisplatin Plus Pemetrexed Chemotherapy: A Case Report. (2024/01/01) ♡
• Early Changes in Nutritional Status of Elderly Patients with Lung Cancer Undergoing Chemotherapy Are Positively Related with Symptoms of Depression: A Prospective Follow-Up Study. (2024/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Omega-3 Fatty Acids Increase Weight and Quality of Life Scores in Patients With Advanced Non-Small Cell Lung Cancer and Cancer Cachexia: A Meta-Analysis. (2024/01/01) ♡
• The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC. (2024/01/01) ♡
• Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report. (2024/01/01) ♡
• The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients. (2024/01/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Phytochemicals as estrogen receptor modulators? -a commentary of a network pharmacology study of two commonly employed Chinese herbal medicines in non-small cell lung cancer treatment. (2023/12/31) ♡
• Cinobufotalin effect and mechanism on serum MMP-2, MMP-9, Beclin1, LC3-II in advanced NSCLC patients. (2023/12/31) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unusual Presentation of Primary Pulmonary Sarcomatous Cancer With Brain Metastasis: A Case Report. (2023/12/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Association Between ALK Rearrangement and Ultra-Late Recurrence in Lung Cancer: Case Report and Pooled Analysis. (2023/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer. (2023/12/29) ♡
• Localization of Sites of Osimertinib Action in Rat Intestine, Skin, and Lung by Immunohistochemistry. (2023/12/28) ♡
• Genomic Landscape of NSCLC in the Republic of Ireland. (2023/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Rechallenge of Trastuzumab Deruxtecan After Drug-Induced Interstitial Lung Disease in a NSCLC With HER2 Mutation: A Case Report. (2023/12/26) ♡
• Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315). (2023/12/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Novel BRD2: :NUTM1 Fusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report. (2023/12/23) ♡
• KIFC1 aggravates non-small-cell lung cancer cell proliferation and metastasis via provoking TGF-β/SMAD signal. (2023/12/20) ♡
• RNF213 inhibits migration in lung adenocarcinoma cell. (2023/12/20) ♡
• Long-non-coding RNA AK001058: A genetic biomarker in cisplatin sensitivity of non-small-cell lung carcinoma. (2023/12/20) ♡
• Effect of AGES-rage system on the efficacy of PD-1 inhibitors in the treatment of driver gene mutation negative advanced non-squamous non-small cell lung cancer. (2023/12/20) ♡
• The expression level of fibroblast growth factor gene in serum samples of lung cancer patients (2023/12/20) ♡
• Evaluation of use of hyperbaric oxygen in suppression of hyperproliferation in hypoxic NSCLC cells (2023/12/20) ♡
• ITGA9-AS1 up-regulates ITGA9 by targeting miR-4765 and recruiting HNRNPU to affect the proliferation and apoptosis of non-small cell lung cancer cells. (2023/12/20) ♡
• RAMP2-AS1 stabilized RAPM2 mRNA through TIA1 to inhibit the progression of non-small cell lung cancer. (2023/12/20) ♡
• Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKiS) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations. (2023/12/19) ♡
• RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants. (2023/12/19) ♡
• Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? (2023/12/18) ♡
• A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC. (2023/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The First Case Report of Effective Treatment With Sotorasib for Metastatic Atypical Lung Carcinoid Harboring KRAS G12C Mutation and Aggressive Disseminated Lung Metastasis: A Case Report. (2023/12/15) ♡
• VentX promotes tumor specific immunity and efficacy of immune checkpoint inhibitors. (2023/12/14) ♡
• Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity. (2023/12/14) ♡
• Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. (2023/12/13) ♡
• The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer. (2023/12/12) ♡
• Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events. (2023/12/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis. (2023/12/11) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adjunctive effect of compound Kushen injection for cancer: An overview of systematic reviews. (2023/12/05) ♡
• Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer. (2023/12/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effect of Prehabilitation in Lung Cancer Patients Undergoing Lobectomy: A Review. (2023/12/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dabrafenib Therapy and BRAF Genotype. (2023/12/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a narrative review. (2023/12/04) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Suspected NUT carcinoma progressing on pembrolizumab, carboplatin, and paclitaxel as first-line treatment: a case report. (2023/12/02) ♡
• Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. (2023/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Immunotherapy combined with Bianzheng traditional Chinese medicine for advanced lung cancer: A preliminary experience. (2023/12/01) ♡
• Different Endotracheal Intubations for Non-Small Cell Lung Cancer Surgery: A Retrospective-Case-Matched Study on Postoperative Complications and Quality of Life. (2023/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.